GMP MANUAL wins SIPAward
Safe drugs through better GMP understanding
The Special Information Publishers Association (SIPA) hosted the award ceremony in Washington, DC on 07 June, 2016. SIPA is a global association of specialized publishers, of which Maas & Peither has been a member for years. Thomas Peither, Executive Director and Editor in Chief proudly presented the prestigious award to his team: “It was a great honor to accept this award for our team. We work tirelessly and with great dedication to support the GMP community in their daily business. Our current GMP knowledge contributes to make medicinal drug products safer for everybody. We have all earned this award!”
Maas & Peither is based out of Schopfheim, Germany (close to Basel), and supports the commercial medical drug manufacturing with quality assurance information for 17 years.
How to produce safe drugs through better GMP understanding
Good manufacturing practice (GMP) is the set of rules for commercial drug manufacturing defined in regulatory documents of health care authorities all over the world. It is crucial for patients that medicinal drugs are manufactured in uncompromisingly high quality for safety reasons.
It is a major challenge to keep up to date with hundreds of continuously changing global regulations in the GMP sector for the pharmaceutical industry. In addition to identifying new legal requirements – the rules have to be implemented effectively as well.
For the last 10 Years, the GMP MANUAL covers all aspects of GMP in one source to amplify the existing expert knowledge.
The GMP MANUAL helps the customers with reliable and trusted information:
- “GMP in Practice” – covers GMP interpretations written by internationally renowned industry experts, providing practical help.
- “GMP Regulations” – contains continuously updated important GMP regulations from the United States (CFR and FDA) to Europe, also including guidelines published by the PIC/S, the ICH, the WHO and others.
About Maas & Peither AG
Maas & Peither AG, also known as GMP-Verlag, was founded as a specialised publishing house in 1999 and presently employs a staff of 18, with 88 authors and more than 10,000 users world-wide.
Good Manufacturing Practice (GMP) of pharmaceutical products is the main focus of the publishing program. The company is located at the heart of the pharmaceutical industry in the trian-gle formed by Germany, Switzerland and France.
The GMP MANUAL forms the core of the portfolio and has be-come the standard reference work on the topic of GMP in the pharmaceutical industry. This knowledge base is held in high regards by experts worldwide.
Furthermore, approximately 100 additional publications (such as SOPs, risk analyses, checklists, e-learning programmes) provide assistance in implementing GMP requirements in conformity with general practise and regulatory authorities.